REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

NCT01483560 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

493

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

University of Glasgow

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]